课题基金 / 基金详情

Regulatory Mechanism of RANK Gene Expression during Osteoclastic Differentiation of Bone Marrow Macrophage/Monocyte Lineage

Regulatory Mechanism of RANK Gene Expression during Osteoclastic Differentiation of Bone Marrow Macrophage/Monocyte Lineage
骨髓巨噬细胞/单核细胞谱系破骨分化过程中RANK基因表达的调控机制
批准号:
21590419
负责人:
KITAZAWA Riko
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

KITAZAWA Riko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Receptor activator of NF-kappaB(RANK) expressed on osteoclasts and their precursors is a receptor for RANK Ligand(RANKL). RANKL-RANK interaction induces genes essential for the differentiation of osteoclasts through the binding of NFATc1 to target gene promoters. We have cloned a 6-kb fragment containing the 5'-flanking region of the mouse RANK gene and have analyzed the binding elements such as PU. 1(-480), and MITF(-100). Here, we showed the regulatory mechanism of RANK gene transcription through the NFAT(-370) and CRE/AP-1 binding sites(-240). Furthermore, we have identified a novel alternative splicing variant of mouse RANK gene that contains a new intervening exon between exon 1 and exon 2 of mouse full-length RANK mRNA, and shown that variant RANK is a novel osteoclast suppressor that reduces the number of RANKL-induced mature osteoclasts mainly by negating the anti-apoptotic effect of RANKL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Derepression of Mouse SFRP-4 Gene Expression by Oxidative Stress : A Plausible Mechanism Leading to Low-turnover Osteoporosis in Diabetes and Senescence.
氧化应激对小鼠 SFRP-4 基因表达的去抑制:导致糖尿病和衰老中低周转骨质疏松症的合理机制。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Mori K., et al.]
通讯作者: et al.
Oxidative DNA Damage to Methylated CpG Located at Five Bases Upstream of TATA-box Restores Suppressed sFRP-4 Gene Expression : Proposal of A Unique Mechanism towards Diabetic Osteoporosis.
位于 TATA-box 上游五个碱基的甲基化 CpG 的氧化 DNA 损伤可恢复受抑制的 sFRP-4 基因表达:针对糖尿病骨质疏松症的独特机制的提议。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Mori K, et al.]
通讯作者: et al.
DOI: 10.1159/000297290
发表时间: 2010-01-01
期刊: AMERICAN JOURNAL OF NEPHROLOGY
影响因子: 4.2
作者: [Fujii, Hideki, Kono, Keiji, Fukagawa, Masafumi]
通讯作者: Fukagawa, Masafumi
Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia
转基因小鼠中硫氧还蛋白-1 过度表达可减轻链脲佐菌素诱导的糖尿病骨质减少
DOI: --
发表时间: 2009
期刊: Bone 44
影响因子: --
作者: [Hamada Y., et al.]
通讯作者: et al.
25
    Analysis of transcriptional regulation of RANK gene and osteoclastic differentiation in bone marrow microenvironment
    • 批准号:
      18590372
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.42万
    • 财政年份:
      2006
    • 负责人:
      KITAZAWA Riko
    • 依托单位:
    ROLE OF RANKL IN OSTEOLYTIC BONE METASTASIS
    • 批准号:
      16590313
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2004
    • 负责人:
      KITAZAWA Riko
    • 依托单位:
    REGULATORY MECHANISM OF RANKL GENE EXPRESSION
    • 批准号:
      14570188
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2002
    • 负责人:
      KITAZAWA Riko
    • 依托单位:
    ANALYSIS OF THE GENE PROMOTERS OF MOUSE OSTEOCLAST DIFFERENTIATION FCTOR (RANKL)
    • 批准号:
      12670204
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2000
    • 负责人:
      KITAZAWA Riko
    • 依托单位:
    国内基金
    海外基金
    基于RANKL/RANK/OPG通路观察补肾活血方干预半月板白-白区撕裂后软骨下骨的研究
    基于“阴消阳长”理论从RANKL/RANK通路探讨阳和汤调控骨转移乳腺癌免疫微环境增敏免疫的机制研究
    • 批准号:
      2026JJ50610
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      毛丹
    • 依托单位:
    单核巨噬细胞通过RANK/RANKL/OPG 信号通路调控小鼠P3趾尖骨关节再生的机制研究
    • 批准号:
      JCZRYB202500176
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    OPG-RANKL-RANK轴调控NLRP3炎症小体介导DA神经元变性的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈祥
    • 依托单位: